Show simple item record

dc.contributor.authorChen, Yin Ching I.
dc.contributor.authorBrownell, Anna-Liisa
dc.contributor.authorGalpern, Wendy R.
dc.contributor.authorIsacson, Ole
dc.contributor.authorBogdanov, Mikhail
dc.contributor.authorBeal, M. Flint
dc.contributor.authorLivni, Eli
dc.contributor.authorRosen, Bruce R.
dc.contributor.authorJenkins, Bruce G.
dc.date2022-08-11T08:08:56.000
dc.date.accessioned2022-08-23T16:12:54Z
dc.date.available2022-08-23T16:12:54Z
dc.date.issued1999-11-05
dc.date.submitted2008-08-19
dc.identifier.citationNeuroreport. 1999 Sep 29;10(14):2881-6.
dc.identifier.issn0959-4965 (Print)
dc.identifier.pmid10549790
dc.identifier.urihttp://hdl.handle.net/20.500.14038/33494
dc.description.abstractWe demonstrate the use of magnetic resonance imaging (MRI) for detection of neurotransmitter stimulation using the dopamine transporter ligands amphetamine and CFT (2beta-carbomethoxy-3beta-(4-fluorophenyl)tropane) as pharmacological challenges. We demonstrate that the unilateral loss of a hemodynamic response to either amphetamine or CFT challenge by unilateral 6-hydroxydopamine lesioning is restored by transplantation of fetal dopamine neurons in the striatum. The time course for the hemodynamic changes parallels the time courses for dopamine release, measured by prior microdialysis studies, and also for the rotational behavior in the unilaterally lesioned animals. Transplantation of the fetal cells results in hemodynamic time courses after CFT or amphetamine challenges at the graft site that are identical to those induced both before transplantation and on the intact contralateral side. The transplantation also results in complete behavioral recovery. The spatial extent of the dopaminergic recovery in the lesioned striatum is the same when measured using either PET of tracer levels of [11C]CFT binding or MRI. These results show great promise for the application of pharmacological MRI for application to studies of dopamine cell loss and potential recovery in Parkinson's disease.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10549790&dopt=Abstract ">Link to article in PubMed</a>
dc.relation.urlhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00001756-199909290-00001&LSLINK=80&D=ovft
dc.subjectAmphetamine; Animals; Behavior, Animal; Cell Transplantation; Cocaine; Dopamine; Dopamine Uptake Inhibitors; Female; Magnetic Resonance Imaging; Microdialysis; Neurons; Rats; Rats, Sprague-Dawley; Striatonigral Degeneration; Sympathectomy, Chemical; Tomography, Emission-Computed
dc.subjectLife Sciences
dc.subjectMedicine and Health Sciences
dc.titleDetection of dopaminergic cell loss and neural transplantation using pharmacological MRI, PET and behavioral assessment
dc.typeJournal Article
dc.source.journaltitleNeuroreport azabicyclo(3.2.1)octane-2-carboxylic acid, methyl ester)
dc.source.volume10
dc.source.issue14
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/gsbs_sp/202
dc.identifier.contextkey586720
html.description.abstract<p>We demonstrate the use of magnetic resonance imaging (MRI) for detection of neurotransmitter stimulation using the dopamine transporter ligands amphetamine and CFT (2beta-carbomethoxy-3beta-(4-fluorophenyl)tropane) as pharmacological challenges. We demonstrate that the unilateral loss of a hemodynamic response to either amphetamine or CFT challenge by unilateral 6-hydroxydopamine lesioning is restored by transplantation of fetal dopamine neurons in the striatum. The time course for the hemodynamic changes parallels the time courses for dopamine release, measured by prior microdialysis studies, and also for the rotational behavior in the unilaterally lesioned animals. Transplantation of the fetal cells results in hemodynamic time courses after CFT or amphetamine challenges at the graft site that are identical to those induced both before transplantation and on the intact contralateral side. The transplantation also results in complete behavioral recovery. The spatial extent of the dopaminergic recovery in the lesioned striatum is the same when measured using either PET of tracer levels of [11C]CFT binding or MRI. These results show great promise for the application of pharmacological MRI for application to studies of dopamine cell loss and potential recovery in Parkinson's disease.</p>
dc.identifier.submissionpathgsbs_sp/202
dc.contributor.departmentGraduate School of Biomedical Sciences
dc.source.pages2881-6


This item appears in the following Collection(s)

Show simple item record